Base Year
Historical Year
Forecast Year
The nocturia market size was valued at USD 3.3 billion in 2023, driven by the rising prevalence of nocturia across the 8 major markets. The market is expected to grow at a CAGR of 8.3% during the forecast period of 2024-2032, with the values likely to rise from USD 3.5 billion in 2024 to USD 6.6 billion by 2032.
Nocturia is a medical condition characterized by excessive urination at night, with the affected individual visiting the bathroom twice or more at nighttime. Patients with nocturia can suffer from sleep deprivation which can greatly impact the quality of life. It is also linked with obesity, depression, diabetes, and heart disease, among others.
The market is driven by the rising prevalence of nocturia, with over 50% of men and women aged 60 or more reported to be diagnosed with the condition. The incidence of nocturia in older men is higher than in older women, amounting to 50% in men between 70 to 79 years having two or more nightly voids. The growing number of patients with nocturia is expected to directly drive the nocturia market demand, with more and more individuals seeking effective treatment options to manage the symptoms.
As people age, they are more likely to experience nocturia, which also tends to become more severe. With the rising geriatric population, clinically significant nocturia cases are expected to surge. According to the United Nations Population Fund, the number of older people aged 60 years, or more is expected to reach 2.1 billion worldwide, accounting for 22% of the total population. Moreover, it is estimated that the elderly population in India will double, almost reaching 347 million in 2050. This indicates that the rapid growth of the geriatric population is likely to augment nocturia market share in the coming years.
The market is also supported by increased research initiatives aimed at finding innovative treatment solutions to treat nocturia. In April 2023, a randomized controlled trial revealed the potential of Erbium YAG laser treatment to manage overactive bladder, often accompanied by frequent urination and nocturia. The study showed positive results, with women receiving the intervention reporting less nocturia and urination urgency, along with additional benefits. The development of such novel treatment methods is anticipated to boost nocturia market growth.
Other factors that impact the market dynamics include the growing technological advancements in diagnostic tools and digital health applications for monitoring symptoms and treatment efficacy. Rising healthcare expenditure, and the introduction of advanced therapies also impact the market significantly. Moreover, the market is expected to witness increased demand owing to the high prevalence rate of chronic conditions such as obesity and hypertension that make an individual prone to nocturia.
| Key Trends | Impact |
| Advancements in Treatment Options | Technological advancements coupled with pharmaceutical progressions have led to the development of new and improved treatment options for nocturia. From behavioral interventions to pharmacotherapy and surgical procedures, the rising accessibility of these therapeutic interventions is fuelling the nocturia market share. Further, the market is witnessing a diversification of available treatments, which attracts a wider patient base, thereby driving market demand. |
| Integration of Digital Health Technologies | The integration of digital health technologies, such as mobile apps for bladder monitoring and telehealth services for remote consultations, is significantly impacting the market landscape. With the help of these digital tools, patient management along with adherence to treatment plans are likely to improve. This market trend follows a patient-centric approach by leveraging digital solutions, focusing on the convenience of the patients, and is expected to bolster nocturia market demand in the coming years. |
| Heightened Awareness and Diagnosis | The rising awareness among the public and healthcare professionals about nocturia as a treatable condition, rather than a normal part of aging, has accelerated diagnosis rates and encouraged treatment-seeking behaviour. Moreover, this trend also supports ongoing research and development aimed at finding effective therapeutics to treat nocturia, contributing to market growth and innovation in the healthcare sector. |
| Rising Healthcare Expenditure | One of the significant nocturia market trends is the increased healthcare expenditure that enables substantial investment in the diagnosis and treatment of nocturia. This is expected to accelerate the development of advanced therapies more accessible to a broader patient population. This financial investment also supports the adoption of innovative medical technologies, further driving market growth. |
Market Breakup by Disease Type
The market is segmented by disease type into polyuria, nocturnal polyuria, low nocturnal bladder capacity, and mixed nocturia. In about 88% of patients , the cause of nocturia is nocturnal polyuria which is characterized by greater production of urine during nighttime.
Market Breakup by Drug Type
In terms of drug type, the market comprises anti-cholinergic drugs, desmopressin, antibiotics, anti-spasmodic, and other medications targeting various aspects of nocturia management. This market segment reflects the range of medications usually prescribed for treating nocturia. For instance, desmopressin is an antidiuretic that is usually given to nocturia patients to reduce the amount of urine produced.
Market Breakup by Dosage Form
The nocturia market share by dosage forms includes tablets and nasal sprays. This segment offers different administration options according to specific patient needs and convenience.
Market Breakup by Distribution Channel
Distribution channels for nocturia drugs are hospital pharmacies, drug stores, retail pharmacies, and online pharmacies. This segment provides various facilities or healthcare settings for patients to access medications.
Market Breakup by Region
Based on the region, the nocturia market segmentation includes the United States, EU-4 (Germany, France, Italy, Spain), and the United Kingdom, Japan, and India. United States holds a significant portion of the market which can be attributed to the high prevalence rate of the disease in the region. It is estimated that 50 million individuals are affected by the condition, which can severely impact the overall health and daytime functioning of the patient. The rising number of nocturia cases along with heightened patient awareness and diagnostic rates are expected to drive the market demand in the regional market.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Disease Type |
|
| Breakup by Drug Type |
|
| Breakup by Dosage Form |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The market attained a value of about USD 3.3 billion in 2023 driven by the rising prevalence of nocturia across the 8 major markets.
The market is anticipated to grow at a CAGR of 8.3% during the forecast period of 2024-2032, likely to reach a market value of USD 6.6 billion by 2032.
The market demand is driven by heightened patient awareness and rising healthcare expenditure.
One of the significant trends in the market is increased research initiatives aimed at finding innovative treatment solutions to treat nocturia. In April 2023, a trial revealed the potential of Erbium YAG laser treatment to manage overactive bladder, often accompanied by frequent urination and nocturia.
Based on the disease type, the market is segmented into polyuria, nocturnal polyuria, low nocturnal bladder capacity, and mixed nocturia.
Based on the drug type, the market is segmented into anti-cholinergic drugs, desmopressin, antibiotics, anti-spasmodics, and other medications.
Various dosage forms in the market are tablets and nasal sprays.
Distribution channels in the market include hospital pharmacies, drug stores, retail pharmacies, and online pharmacies.
The major regions of the market include the United States, EU-4 (Germany, France, Italy, Spain), the United Kingdom, Japan, and India.
Key players involved in the market are Urigen Pharmaceuticals, Glenmark Pharmaceuticals, AbbVie Inc., Teva Pharmaceuticals, Avadel Pharmaceuticals, Astellas Pharma, Dainippon Sumitomo Pharma, Feering Pharmaceuticals, AA Pharma Inc., and Pfizer Inc.
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share